FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

38705511000001109: Tavlesse 100mg tablets (Grifols UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Jul 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1478151000001116 Tavlesse 100mg tablets (Grifols UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1478161000001118 Tavlesse 100mg tablets (Grifols UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tavlesse 100mg tablets (Grifols UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Tavlesse 100mg tablets (Grifols UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tavlesse 100mg tablets (Grifols UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Tavlesse 100mg tablets (Grifols UK Ltd) Is a Fostamatinib 100mg tablets true Inferred relationship Existential restriction modifier
Tavlesse 100mg tablets (Grifols UK Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Tavlesse 100mg tablets (Grifols UK Ltd) Is a Tavlesse true Inferred relationship Existential restriction modifier
Tavlesse 100mg tablets (Grifols UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tavlesse 100mg tablets (Grifols UK Ltd) Has specific active ingredient Fostamatinib disodium hexahydrate true Inferred relationship Existential restriction modifier
Tavlesse 100mg tablets (Grifols UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tavlesse 100mg tablets (Grifols UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tavlesse 100mg tablets (Grifols UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Tavlesse 100mg tablets (Grifols UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Fostamatinib false Inferred relationship Existential restriction modifier
Tavlesse 100mg tablets (Grifols UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Fostamatinib true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Tavlesse 100mg tablets (Grifols UK Ltd) 60 tablet Has AMP True Tavlesse 100mg tablets (Grifols UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start